Pityriasis rosea-like rash after COVID-19 vaccination with Oxford-AstraZeneca: a possible trigger?
Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-CoV-2. However, vaccines have produced adverse effects in some patients. We report the case of a 44-year-old man who developed a pruritic papulosquamous rash on the trunk with a characteristic patter...
Main Authors: | Fernando Eibs Cafrune, Marina Resener de Morais, Mariele Bevilaqua, Luyze Homem de Jesus |
---|---|
Format: | Article |
Language: | English |
Published: |
Hospital de Clinicas de Porto Alegre ; Universidade Federal do Rio Grande do Sul (UFRGS)
2023-01-01
|
Series: | Clinical and Biomedical Research |
Online Access: | https://seer.ufrgs.br/index.php/hcpa/article/view/123192 |
Similar Items
-
Thromboembolism and the Oxford-AstraZeneca vaccine
by: Perera, R, et al.
Published: (2021) -
Malaysia to use AstraZeneca vaccine
by: Povera, Adib
Published: (2021) -
Membranoproliferative Glomerulonephritis following the Oxford AstraZeneca COVID-19 Vaccine
by: Kawtar Hassani, et al.
Published: (2021-01-01) -
Immunogenicity of Oxford-AstraZeneca COVID-19 vaccine in Vietnamese healthcare workers
by: Van Vinh Chau, N, et al.
Published: (2021) -
Busting the Breast Cancer with AstraZeneca’s Gefitinib
by: S. Chemmalar, et al.
Published: (2023-01-01)